These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7538710)

  • 1. [The effectiveness of beta-sitosterol in treatment of benign prostatic hyperplasia].
    Senge T; Windeler J; Berges RR; Trampisch HJ
    Urologe A; 1995 Mar; 34(2):130-1. PubMed ID: 7538710
    [No Abstract]   [Full Text] [Related]  

  • 2. Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia.
    Kaplan SA
    J Urol; 2005 Sep; 174(3):1011. PubMed ID: 16094031
    [No Abstract]   [Full Text] [Related]  

  • 3. [Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia].
    Urologe A; 2003 Feb; 42(2):301-2. PubMed ID: 12739514
    [No Abstract]   [Full Text] [Related]  

  • 4. A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. German BPH-Phyto Study group.
    Klippel KF; Hiltl DM; Schipp B
    Br J Urol; 1997 Sep; 80(3):427-32. PubMed ID: 9313662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Conservative therapy of prostatic adenoma as well as prostatitis with beta-sitosterol prostate capsules].
    Karcher G
    Med Welt; 1982 Dec; 33(48):1763-6. PubMed ID: 6185822
    [No Abstract]   [Full Text] [Related]  

  • 6. [Alfuzosin in benign prostatic hyperplasia. A new principle is evaluated. Report of a study].
    Fortschr Med Suppl; 1995; 166():1-12. PubMed ID: 7537599
    [No Abstract]   [Full Text] [Related]  

  • 7. [New in Austria approved specialty drugs and new knowledge regarding currently available specialty drugs. Uroflo].
    Wien Klin Wochenschr; 1995; 107(15):472-6. PubMed ID: 7545857
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of short-term treatment with the alpha 1-blocker alfuzosin on urodynamic pressure/flow parameters in patients with benign prostatic hyperplasia.
    Martorana G; Giberti C; Di Silverio F; von Heland M; Rigatti P; Colombo R; Casadei G; Pacifico P
    Eur Urol; 1997; 32(1):47-53. PubMed ID: 9266231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two drugs have a better outcome. Finasteride plus alpha blocker improves urine flow].
    MMW Fortschr Med; 2003 Nov; 145(47):62. PubMed ID: 14725041
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemo-ablation of the prostate with dehydrated alcohol for the treatment of prostatic obstruction.
    Ditrolio J; Patel P; Watson RA; Irwin RJ
    J Urol; 2002 May; 167(5):2100-3; discussion 2103-4. PubMed ID: 11956449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of a double-blind study on the effectiveness of ERU (extractum radicis Urticae) capsules in conservative treatment of benign prostatic hyperplasia].
    Vontobel HP; Herzog R; Rutishauser G; Kres H
    Urologe A; 1985 Jan; 24(1):49-51. PubMed ID: 2580383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study Group.
    Berges RR; Windeler J; Trampisch HJ; Senge T
    Lancet; 1995 Jun; 345(8964):1529-32. PubMed ID: 7540705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the effectiveness of prazosin in conservative treatment of benign prostatic hypertrophy].
    Górecki R; Krzeski T; Wasik J; Borówka A
    Pol Tyg Lek; 1992 Jun 15-29; 47(24-26):549-51. PubMed ID: 1282713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Benign prostatic syndrome. Urinary urgency and micturition frequency reduced with plant preparation].
    MMW Fortschr Med; 2005 Oct; 147(40):52-3. PubMed ID: 16255520
    [No Abstract]   [Full Text] [Related]  

  • 15. Defining the role of overactive bladder treatments in men with lower urinary tract symptoms.
    Lemack GE
    Nat Clin Pract Urol; 2007 Apr; 4(4):174-5. PubMed ID: 17415351
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of isosorbide dinitrate on the urinary flow rate in patients with benign prostatic hyperplasia.
    Roshani A; Khosropanah I; Salehi M; Kamran AN
    Urol J; 2010; 7(3):183-7. PubMed ID: 20845295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
    Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
    J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug therapy of benign prostatic hyperplasia].
    Vahlensieck W; Fabricius PG; Hell U
    Fortschr Med; 1996 Nov; 114(31):407-11. PubMed ID: 9036092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pikamilone treatment of benign prostatic hyperplasia].
    Tolstova SS
    Urologiia; 1999; (5):6-7. PubMed ID: 11150159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of benign prostatic hyperplasia with phytosterols.
    Carbin BE; Larsson B; Lindahl O
    Br J Urol; 1990 Dec; 66(6):639-41. PubMed ID: 1702340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.